FI883177A0 - ANVAENDNING AV ETT MEDIUM MED HOEG AFFINITET FOER TUMOERER. - Google Patents

ANVAENDNING AV ETT MEDIUM MED HOEG AFFINITET FOER TUMOERER.

Info

Publication number
FI883177A0
FI883177A0 FI883177A FI883177A FI883177A0 FI 883177 A0 FI883177 A0 FI 883177A0 FI 883177 A FI883177 A FI 883177A FI 883177 A FI883177 A FI 883177A FI 883177 A0 FI883177 A0 FI 883177A0
Authority
FI
Finland
Prior art keywords
tumoerer
affinitet
anvaendning
foer
medium med
Prior art date
Application number
FI883177A
Other languages
Finnish (fi)
Other versions
FI883177A (en
Inventor
Sirkka-Liisa Karonen
Jan Lindgren
Hannu Aronen
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of FI883177A0 publication Critical patent/FI883177A0/en
Publication of FI883177A publication Critical patent/FI883177A/en
Priority to FI942151A priority Critical patent/FI942151A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Optics & Photonics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Motorcycle And Bicycle Frame (AREA)
  • Steroid Compounds (AREA)

Abstract

The vehicle consists of tissue plasminogen activator or an essential part thereof and is used both for the diagnosis and therapy of malignant tumours.
FI883177A 1987-07-08 1988-07-04 ANVAENDNING AV ETT MEDIUM MED HOEG AFFINITET FOER TUMOERER. FI883177A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI942151A FI942151A0 (en) 1987-07-08 1994-05-10 Use of a medium with a high affinity for tumors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873722522 DE3722522A1 (en) 1987-07-08 1987-07-08 USE OF A VEHICLE WITH HIGH AFFINITY TO TUMORS

Publications (2)

Publication Number Publication Date
FI883177A0 true FI883177A0 (en) 1988-07-04
FI883177A FI883177A (en) 1989-01-09

Family

ID=6331118

Family Applications (1)

Application Number Title Priority Date Filing Date
FI883177A FI883177A (en) 1987-07-08 1988-07-04 ANVAENDNING AV ETT MEDIUM MED HOEG AFFINITET FOER TUMOERER.

Country Status (13)

Country Link
EP (1) EP0298436B1 (en)
JP (1) JPH01125331A (en)
KR (1) KR890001508A (en)
AT (1) ATE81473T1 (en)
AU (1) AU623080B2 (en)
DE (2) DE3722522A1 (en)
DK (1) DK167561B1 (en)
ES (1) ES2046244T3 (en)
FI (1) FI883177A (en)
GR (1) GR3006404T3 (en)
NO (1) NO883040L (en)
NZ (1) NZ225350A (en)
ZA (1) ZA884870B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA831399B (en) * 1982-03-05 1984-02-29 Health Lab Service Board New fibrinolytic enzymes and methods for their production and pharmaceutical compositions containing them
US4663146A (en) * 1983-07-29 1987-05-05 Codon Genetic Engineering Laboratories Methods and compositions for the diagnosis of bloodclots using plasminogen activator

Also Published As

Publication number Publication date
DE3875290D1 (en) 1992-11-19
GR3006404T3 (en) 1993-06-21
DK377588D0 (en) 1988-07-07
NO883040D0 (en) 1988-07-07
FI883177A (en) 1989-01-09
JPH01125331A (en) 1989-05-17
EP0298436A2 (en) 1989-01-11
NZ225350A (en) 1991-07-26
KR890001508A (en) 1989-03-27
NO883040L (en) 1989-01-09
DK377588A (en) 1989-01-09
EP0298436A3 (en) 1990-01-17
AU623080B2 (en) 1992-05-07
DE3722522A1 (en) 1989-01-19
ZA884870B (en) 1989-04-26
ES2046244T3 (en) 1994-02-01
AU1889588A (en) 1989-01-12
ATE81473T1 (en) 1992-10-15
EP0298436B1 (en) 1992-10-14
DK167561B1 (en) 1993-11-22

Similar Documents

Publication Publication Date Title
DK0566601T3 (en) Echo contrast medium
SE8005256L (en) FRAMSTELLNINGSFORFARANDE
EP0335910A4 (en) Intraoperative and endoscopic tumor detection and therapy.
NO175158C (en) Preparation of human uterine tissue plasminogen activator with recombinant DNA
ATE61000T1 (en) METHODS TO INCREASE TARGET SPECIFICITY IN ANTIBODY DETERMINATIONS AND REMOVE NON-TARGET-SPECIFIC DIAGNOSTIC AND THERAPEUTIC FACTORS.
NO170886C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF NEW THERAPEUTIC ACTIVE BENZOTIOPHENES
SE8404283L (en) APPLICATION OF A SPECIFIC TUMORALLY ASSOCIATED ANTIGEN, namely SIALOSYLLACTOTETRAUS, FOR DIAGNOSTIC AND THERAPEUTIC PROCEDURES FOR CANCER DISEASES
ATE132187T1 (en) BAT SALIVA PLASMINOGEN ACTIVator VPA-ALPHA 1
FI101597B1 (en) A method of preparing a lyophilized composition for use in photodynamic therapy or diagnosis of a patient
NO164353C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRIDOPYRIMIDINES.
FI883177A0 (en) ANVAENDNING AV ETT MEDIUM MED HOEG AFFINITET FOER TUMOERER.
IT1147788B (en) PROCEDURE FOR THE PREPARATION OF PLASMINOGEN ACTIVATORS USEFUL AS THERAPEUTIC AND DIAGNOSTIC AGENTS
DE3764697D1 (en) MEDICAL PREPARATION CONTAINING T-PA AND THEIR USE.
FI844645L (en) 1,7-DIPHENYL-3-METHYLAZA-7-CYAN-8-METHYL-NONAN FOR ANALYSIS OF THE CONSTRUCTION OF SJUKDOMAR.
ZA877900B (en) Active compounds for preventing tumor metastases
ES2040765T3 (en) PROCEDURE FOR PREPARING AN AGENT FOR THE TREATMENT OF ANGIOGENIC DISEASES OR TUMORS.
NO901995L (en) NEW VARIANT OF HUMAN Tissue PLASMINOGEN ACTIVATOR.
ATE75938T1 (en) THERAPEUTIC AGENT CONTAINING ENANTIOMERS OF PROPAFENONE.
DE69113437D1 (en) Therapeutic agents for diabetic gangrene.
IT8048370A0 (en) AGENT FOR THE DIAGNOSIS OF TUMORS AND PROCEDURE FOR ITS TREATMENT
UA13670A1 (en) Agent for presowing seed tratment
AU3430189A (en) Compounds for diagnosis and/or therapy of tumours

Legal Events

Date Code Title Description
FD Application lapsed
MM Patent lapsed

Owner name: BOEHRINGER INGELHEIM INTERNATIONAL GMBH